-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
April 2016
-
Alex A. Adjei, MD, PhD, FACP
Alex A. Adjei, MD, PhD, FACP, has been appointed Professor of Oncology at Mayo Clinic, Rochester, US. He is also Director of the Early Cancer Therapeutics Program and Director of Global Oncology at Mayo’s three sites in Arizona, Florida, and Minnesota. Dr. Adjei is Editor-in-Chief of the Journal of Thoracic Oncology and previously was Professor…
-
IASLC and ESMO Present 6th European Lung Cancer Conference
By Nicola M. Parry, DVM From April 13-16, 2016, the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO) will once again join forces to host the 6th European Lung Cancer Conference (ELCC) at Palexpo in Geneva, Switzerland. This meeting is a collaborative effort of key multidisciplinary…
-
Welcome from David Carbone, MD, PhD, IASLC President
These are exciting times in lung cancer treatment and research, but there is still a lot of room for improvement in propagating these discoveries to all lung cancer patients around the world, and converting responses to cures; in this context, as President of the International Association for the Study of Lung Cancer, I am pleased…
-
From the Editor / Corey J. Langer, MD, FACP
Greetings. It is my privilege to introduce the IASLC Lung Cancer News (ILCN). I will be serving as Editor with the able assistance of my Associate Editors, Fabrice Barlesi, MD from Europe and Caicun Zhou, MD from Asia. ILCN is a new tabloid publication that will highlight updates on thoracic malignancy research, including diagnostics, screening,…